-
Klotho Neurosciences Receives FDA Orphan Drug Designation for KLTO-202 in ALS
Jul 10 2025 -
CoRegen Secures $93 Million to Advance Novel Treg Cell Therapies into Clinic
Jul 09 2025 -
Chan Zuckerberg Initiative Launches Center for Personalized CRISPR Cures for Rare Pediatric Diseases
Jul 08 2025 -
Solid Biosciences’ SGT-501 AAV Gene Therapy Cleared for Clinical Trials!
Jul 08 2025 -
Centivax Secures $45M for Universal mRNA Flu Vaccine
Jul 08 2025 -
Mustang Bio Receives FDA Orphan Drug Designation for MB-101 in Difficult-to-Treat Astrocytomas and Glioblastoma
Jul 08 2025 -
Lexeo Therapeutics Gains FDA Breakthrough Therapy Designation for AAV Gene Therapy in Friedreich Ataxia
Jul 07 2025 -
SCG Cell Therapy’s SCG101V Receives NMPA IND Clearance for Chronic Hepatitis B, First-Ever Cell Therapy for HBV
Jul 07 2025 -
Early Data for EsoBiotec’s In Vivo CAR-T Therapy (ESO-T01) in Multiple Myeloma
Jul 07 2025